Immunome Inc Capital Reinvestment Ratio

Latest as of March 2023: 0.00x

Immunome Inc capital reinvestment ratio. Immunome Inc (IMNM) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($24.17 Million) in capital expenditures ($106.00K). See how much free cash does Immunome Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$24.17 Million

USD

Capital Expenditures

$106.00K

USD

Data as of

Mar 2023

Most recent filing

Immunome Inc Capital Reinvestment Ratio by Year (None–None)

Immunome Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see IMNM cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow